Afuco™ Anti-TNFSF13B ADCC Therapeutic Antibody (Belimumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Human BLyS. Belimumab (trade name Benlysta, previously known as LymphoStat-B) is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS). B cells are responsible for part of the normal immune response, and also for the over-aggressive immune response in autoimmune diseases like systemic lupus erythematosus (SLE).
Supplier | Creative Biolabs |
---|---|
Product # | AFC-TAB-030 |
Pricing | Inquiry |
Host | Human |
Target | TNFSF13B |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Applications | FC, IP, ELISA, Neut, FuncS, IF |
Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |